Cargando…

Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer

Epithelial ovarian cancer (EOC) is a gynecological malignancy with high morbidity. Treating EOC remains a challenge, as the pathogenesis of this disease remains unclear and chemoresistance is a common occurrence. A number of previous studies have revealed that obesity is closely associated with canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Fei, Zhang, Hao, Yao, Liangqing, Jiang, Shuheng, Lu, Huan, Xing, Xin, Zhang, Cancan, Jiang, Pengcheng, Zhang, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546982/ https://www.ncbi.nlm.nih.gov/pubmed/31289528 http://dx.doi.org/10.3892/ol.2019.10381

Ejemplares similares

Taxol: an important new drug in the management of epithelial ovarian cancer.
por: Markman, M.
Publicado: (1991)

Platinum-Taxol non-cross resistance in epithelial ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1995)

Role of inhibitor of yes‐associated protein 1 in triple‐negative breast cancer with taxol‐based chemoresistance
por: Li, Ying, et al.
Publicado: (2019)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

Leptin signaling and cancer chemoresistance: Perspectives
por: Candelaria, Pierre V, et al.
Publicado: (2017)

RASSF1A and the Taxol Response in Ovarian Cancer
por: Kassler, Susannah, et al.
Publicado: (2012)

CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer
por: Wessolly, Michael, et al.
Publicado: (2022)

Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses
por: Zhang, Zhengmao, et al.
Publicado: (2019)

SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1
por: Gao, Wujiang, et al.
Publicado: (2022)

Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis
por: Li, Yuan, et al.
Publicado: (2023)

LC-MS Based Sphingolipidomic Study on A2780 Human Ovarian Cancer Cell Line and its Taxol-resistant Strain
por: Huang, Hao, et al.
Publicado: (2016)

Leptin acts on mesenchymal stem cells to promote chemoresistance in osteosarcoma cells
por: Feng, Helin, et al.
Publicado: (2020)

NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017)

Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts
por: LI, WEI, et al.
Publicado: (2013)

Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells
por: Cai, Yongqing, et al.
Publicado: (2018)

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016)

Cross-validation of genes potentially associated with neoadjuvant chemotherapy and platinum-based chemoresistance in epithelial ovarian carcinoma
por: Zhang, Kai, et al.
Publicado: (2020)

Up-regulation of GSTT1 in serous ovarian cancer associated with resistance to TAXOL / carboplatin
por: Zhang, Jing, et al.
Publicado: (2021)

Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience.
por: Gore, M. E., et al.
Publicado: (1995)

Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer
por: Hou, Shunyu, et al.
Publicado: (2018)

Mitochondrial Dynamics Mediated by DRP1 and MFN2 Contributes to Cisplatin Chemoresistance in Human Ovarian Cancer SKOV3 cells
por: Zou, Guang-Ping, et al.
Publicado: (2021)

Chemoresistance Is Associated with MUC1 and Lewis y Antigen Expression in Ovarian Epithelial Cancers
por: Zhang, Danye, et al.
Publicado: (2013)

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
por: Silasi, Dan-Arin, et al.
Publicado: (2007)

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
por: Cheng, W-F, et al.
Publicado: (2009)

Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer
por: Horio, Maiko, et al.
Publicado: (2012)

Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
por: Ip, Carman K. M., et al.
Publicado: (2016)

Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers
por: YING, HUANCHUN, et al.
Publicado: (2015)

Overexpression of Cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer
por: Sui, Hongying, et al.
Publicado: (2016)

NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells
por: Zhou, Ya, et al.
Publicado: (2017)

Adipocytes promote ovarian cancer chemoresistance
por: Yang, Jiang, et al.
Publicado: (2019)

LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells: LIMT contributes to sorafenib chemoresistance in HCC
por: Sun, Jing, et al.
Publicado: (2021)

PSAT1 Regulated Oxidation-Reduction Balance Affects the Growth and Prognosis of Epithelial Ovarian Cancer
por: Zhang, Yiqun, et al.
Publicado: (2020)

Inhibition of CDC25B With WG-391D Impedes the Tumorigenesis of Ovarian Cancer
por: Xiao, Yangjiong, et al.
Publicado: (2019)

Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma
por: FENG, LIN, et al.
Publicado: (2015)

Genomic characterization of Chinese ovarian clear cell carcinoma identifies driver genes by whole exome sequencing
por: Yang, Qin, et al.
Publicado: (2020)

Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro.
por: Jekunen, A. P., et al.
Publicado: (1994)

Effect of taxol on the expression of FoxM1 ovarian cancer-associated gene
por: LIU, ZENG, et al.
Publicado: (2016)

High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer
por: Shen, Yuqing, et al.
Publicado: (2022)

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
por: Chiu, Wen-Tai, et al.
Publicado: (2014)

Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma
por: Lee, Yoo-Young, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ha34gkl8mh82lvflbrpiu92j3j